Skip to main content
logo
X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
4.040
+0.010 (0.25%)
At close: Aug 21, 2026, 4:00 PM EDT
4.127
+0.087 (2.15%)
After-hours: Aug 21, 2026, 7:30 PM EDT

X4 Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
15.8535.112.56---
Revenue Growth
-51.65%1273.21%----
Gross Profit
12.9229.361.76---
Operating Income
-80.67-79.88-141.4-107.52-88.08-75.35
Net Income
-90.14-79.2-37.45-101.17-96.41-102.64
Earnings Per Share
-0.89-1.87-5.59-17.07-45.53-119.59
EPS Growth
------

Revenue by Geography
Chart
Fiscal YearTTMFY 2025FY 2024
Period EndingJun '26 Dec '25 Dec '24
United States
8.66.52.6
United Kingdom
7.228.6-
Total
15.835.12.6

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
207.97253102.06114.22121.7281.79
Total Debt
77.2277.2978.0958.2838.4239.79
Net Cash (Debt)
130.75175.7123.9755.9483.342
Net Cash Growth
-632.93%-57.14%-32.85%98.32%4.33%
Net Cash Per Share
1.284.153.589.4439.3448.94

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-83.74-85.62-130.9-96.51-77.1-70.91
Capital Expenditures
---0.33-0.06-0.1-0.62
Free Cash Flow
-83.74-85.62-131.23-96.57-77.21-71.52
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
81.51%83.60%68.83%---
Operating Margin
-509.06%-227.50%-5529.96%---
Pretax Margin
-568.98%-225.44%-1452.48%---
Profit Margin
-568.80%-225.56%-1464.61%---
FCF Margin
-528.40%-243.84%-5132.07%---

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
25.289.9648.93---